Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This locus encodes a non-coding RNA that is antisense to the UPF3B gene. UPF3B is a protein-coding gene integral to nonsense-mediated mRNA decay (NMD), which eliminates transcripts containing premature stop codons and serves as a critical mRNA quality control pathway[5][7]. The antisense transcript, LOC107985694 (ENSG00000286366), is annotated as a possible regulatory RNA but has not been characterized functionally or linked to disease or therapeutic interventions[1]. It does not produce a protein and its molecular or biological roles remain unclear. For structured information, this entry is best classified as a "non-coding RNA, antisense to UPF3B," with no evidence supporting its role as a therapeutic or druggable target. The locus is included in genomic databases as an annotated, uncharacterized transcript, and is not considered a canonical molecule for pharmacological investigation[1].
None established (no drugs target this molecule; mechanisms such as RNA interference or antisense modulation are theoretical and not documented for this transcript)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to UPF3B (ENSG00000286366).